Palantir’s (NASDAQ: PLTR) overall stock market decline in 2026 has done little to dampen Wall Street enthusiasm ahead of the May 4 earnings, with an overwhelming majority of rating revisions in the last 30 days being positive.
The latest to follow this trend was Param Singh of Oppenheimer, who, on April 30, initiated coverage of the technology giant with a positive recommendation.
Specifically, the Wall Street analyst identified three key aspects that mean that Palantir merits the ‘Outperform’ – ‘Buy’ – rating. First of these is the fact that, according to Param Singh, once a company has adopted and Ontology-related system, they find themselves with a sticky product due to difficulties in switching.
Additionally, Palantir is in the process of rapidly expanding within traditional commercial enterprise organizations and turning itself into a best-in-class vendor, while simultaneously benefiting from its involvement with the U.S. military – especially as President Donald Trump’s desired $1.5 trillion defense budget looms large.
Under the circumstances and despite valuation risks that arose from PLTR’s remarkable rally between early 2023 and late 2025 – and an upsurge that eventually led the stock from under $8 to $138.45 at press time – Oppenheimer foresees a 12-month rise to $200 for the equity.
Wall Street sets Palantir stock price target for the next 12 months
Zooming out, it is evident that Param Singh is far from the only Wall Street analyst to view PLTR shares favorably.
Overall, Palantir is rated as a ‘Moderate Buy,’ and is, on average, expected to rally 38.83% to $191.74 in the coming 52 weeks, per the data Finbold retrieved from the stock analysis platform TipRanks on April 30.
Furthermore, out of the 9 rating revisions issued in the last 30 days, all but three have featured a ‘Buy’ recommendation. Of these, Wedbush’s Dan Ives proved the most bullish, having not only ranked PLTR stock as a ‘Buy,’ but also set his 12-month price target at $230 for a 66.12% rally from the press time price of $138.45.
Simultaneously, Rishi Jaluria of RBC Capital was the only bear with the timeframe, and he issued a ‘Sell’ recommendation for Palantir shares while forecasting a 35% decline to $90.
Featured image via Shutterstock
